These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23484757)

  • 1. Genome-wide screening for drug discovery and companion diagnostics.
    Roses AD
    Expert Opin Drug Discov; 2007 Apr; 2(4):489-501. PubMed ID: 23484757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The medical and economic roles of pipeline pharmacogenetics: Alzheimer's disease as a model of efficacy and HLA-B(*)5701 as a model of safety.
    Roses AD
    Neuropsychopharmacology; 2009 Jan; 34(1):6-17. PubMed ID: 18923406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).
    Roses AD; Saunders AM; Huang Y; Strum J; Weisgraber KH; Mahley RW
    Pharmacogenomics J; 2007 Feb; 7(1):10-28. PubMed ID: 16770341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of whole-genome association scans in disease gene identification, drug discovery and development.
    Roses AD; St Jean PL; Ehm MG
    IDrugs; 2007 Nov; 10(11):797-804. PubMed ID: 17968762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic gene knock-outs: functional genomics and therapeutic target selection.
    Harris S; Foord SM
    Pharmacogenomics; 2000 Nov; 1(4):433-43. PubMed ID: 11257927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biomarkers: "Found in translation"].
    Lockhart BP; Walther B
    Med Sci (Paris); 2009 Apr; 25(4):423-30. PubMed ID: 19409197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics in drug discovery and development: a translational perspective.
    Roses AD
    Nat Rev Drug Discov; 2008 Oct; 7(10):807-17. PubMed ID: 18806753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating genomics across drug discovery and development.
    Debouck C
    Toxicol Lett; 2009 Apr; 186(1):9-12. PubMed ID: 18930125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming regulatory and economic challenges facing pharmacogenomics.
    Cohen JP
    N Biotechnol; 2012 Sep; 29(6):751-6. PubMed ID: 22370122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using biointelligence to search the cancer genome: an epistemological perspective on knowledge recovery strategies to enable precision medical genomics.
    Mousses S; Kiefer J; Von Hoff D; Trent J
    Oncogene; 2008 Dec; 27 Suppl 2():S58-66. PubMed ID: 19956181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Host genetic epidemiology by single nucleotide polymorphism(SNP) analysis].
    Shin HD
    Exp Mol Med; 2001 Apr; 33(1 Suppl):51-69. PubMed ID: 11708326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perlegen sciences, inc.
    Peacock E; Whiteley P
    Pharmacogenomics; 2005 Jun; 6(4):439-42. PubMed ID: 16004563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics and drug development: the path to safer and more effective drugs.
    Roses AD
    Nat Rev Genet; 2004 Sep; 5(9):645-56. PubMed ID: 15372086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When will the genomics investment pay off for antibacterial discovery?
    Mills SD
    Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomics in drug discovery: the best things come to those who wait.
    Bansal AT; Barnes MR
    Curr Opin Drug Discov Devel; 2008 May; 11(3):303-11. PubMed ID: 18428083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.